Skip to main content
. 2016 Jan 7;7(1):44–65. doi: 10.3945/an.115.009639

TABLE 6.

Summary of research studies that tested polyphenolic components of red raspberries in models of obesity1

Results
Source (reference) Model (study type) Study details Treatment Insulin Glucose Other
Park (144) Adipocytes (in vitro) Elucidated a possible mechanism for the antiobesity action of raspberry ketones in 3T3-L1 adipocytes. Outcomes: expression and the secretion of adiponectin, lipolysis, and fatty acid oxidation. 10 μM raspberry ketones ↑Adiponectin, ↑fatty acid, oxidation, ↓lipid accumulation
Park (145) Adipocytes (in vitro) Elucidates a possible mechanism for antiobese actions of raspberry ketones in 3T3-L1 adipocytes treated from days 2 to 8 of differentiation and mature adipocytes for 24 h on day 12 with different doses of raspberry ketone. Outcomes: expression of adipogenic and lipogenic gene expression in 3T3-L1 adipocytes. 1,10, 20, or 50 μM raspberry ketones ↓Dose-dependent adipocyte differentiation, ↓lipid accumulation
Dose- and stage-specific effects: ↓PPARγ, ↓C/EBPα, ↓aP2, ↓FASN, ↓ACC1, ↓SCD1
Mature cells: ↑ ATGL, ↑HSL, ↑CPT1B
Morimoto (146) Mice (animal) Raspberry ketones on obesity and lipid metabolism. Two interventions: 1) Mice were fed an HFD that included 0.5%, 1%, or 2% raspberry ketone for 10 wk; 2) mice were fed a HFD for 6 wk followed by HFD + 1% raspberry ketones for another 5 wk.Outcomes: BW, liver and adipose tissue weight, hepatic triacylglycerol content, NE-induced lipolysis, HSL, and translocation. HFD with 0%, 0.5%, 1%, or 2% (w:w) raspberry ketones for 10 wk; 1% raspberry ketone + HFD for 6 wk ↓Fat tissue ↑NE-induced lipolysis, ↑HSL translocation
1

Studies are ordered according to study type (in vitro, n = 2; animal, n = 1). ACC1, acetyl-CoA carboxylase-1; aP2, activating protein 2; ATGL, adipose triglyceride lipase; BW, body weight; C/EBPα, enhancer binding protein α CPT1B, carnitine palmitoyl transferase 1B); FASN, fatty acid synthase; HFD, high-fat diet; HSL, hormone-sensitive lipase; NE, norepinephrine; SCD1, stearoyl-CoA desaturase-1; ↓, decreased; ↑, increased; ↔, no effect.